Current trends in drug metabolism and pharmacokinetics
Yuhua Li(Sun Yat-sen University), Huichang Bi(Southern Medical University), Yuanfeng Lyu(Chinese University of Hong Kong), Qiang Meng(Dalian Medical University), Mengbi Yang(Chinese University of Hong Kong), Ai‐Ming Yu(University at Buffalo, State University of New York), Zhong Zuo(Chinese University of Hong Kong), Xiaoyan Chen(Chinese Academy of Sciences), Xin Wang(Shanghai Changning Maternity and Infant Health Hospital), Kexin Liu(Zhejiang Cancer Hospital), Lan Tang(Guangdong Pharmaceutical University), Dongyang Liu(Tongji University), Xiang‐Yu Hou(The University of Sydney)
Cited by 391
Related Papers
Progress, challenges, and future of nanomedicine
|Nano Today|2020|306
RNA therapy: Are we using the right molecules?
|Pharmacology & Therapeutics|2018|172
Human transporters, <scp>PEPT</scp>1/2, facilitate melatonin transportation into mitochondria of cancer cells: An implication of the therapeutic potential
|Journal of Pineal Research|2017|156
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129
Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells
|Analytical and Bioanalytical Chemistry|2013|126